Navigation Links
QRxPharma Limited Announces A$14 Million Placement Together With a Share Purchase Plan
Date:10/1/2010

details of the SPP will be sent to shareholders in due course.  

QRxPharma CEO and Managing Director, Dr John Holaday commented, "We are encouraged by the strong level of support we received for this offering as we progress towards the commercialization of our Dual Opioid portfolio of products. QRxPharma is pleased to be one of the few Australian companies with a drug in the final stages of clinical development."

"MoxDuo has the potential to revolutionize the management of pain from the hospital to the home. We have administered MoxDuo IR to well over 500 patients with moderate to severe pain following bunionectomy or total knee replacement surgery, and data indicate excellent pain relief with a 50-75% reduction in moderate to severe side effects. Results from our Phase 3 studies set the stage for NDA filing with the FDA, and once approved, we anticipate the launch of MoxDuo IR into the US$12 billion marketplace in the US and Europe in 2012," he added.  

Further details regarding the timetable for the Placement and Share Purchase Plan are included in the Annexure to this announcement.

Forward Looking Statements

This release contains forward-looking statements.  Forward-looking statements are statements that are not historical facts; they include statements about our beliefs and expectations.  Any statement in this release that states our intentions, beliefs, expectations or predictions (and the assumptions underlying them) is a forward-looking statement.  These statements are based on plans, estimates and projections as they are currently available to the management of QRxPharma.  Forward-looking statements therefore speak only as of the date they are made, and we undertake no obligation to update publicly any of them in light of new information or future events. By their very nature, forward-looking statements involve risks and uncertainties.  A number of important factors could
'/>"/>

SOURCE QRxPharma Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. QRxPharma Doses First Patients in Phase III Clinical Trial Program for its Dual Opioid Pain Therapy
2. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
3. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
4. QRxPharma Successfully Completes Comparative Study for Dual-Opioid(TM) Pain Therapy
5. QRxPharma Inks Deal with Patheon for the Manufacture of MoxDuo(TM)CR
6. QRxPharma Limited Announces A$21.6 Million Fully Underwritten Capital Raising
7. QRxPharma Initiates Second Pivotal Phase 3 Study of MoxDuo(TM)IR Dual-Opioid(TM) for NDA Submission
8. QRxPharma Limited and China Aoxing Pharmaceutical Company Announce Strategic Alliance for Development of MoxDuo(R)IV
9. QRxPharma Releases Additional Pivotal Phase 3 Combination Rule Study Data for MoxDuo(R)IR in Patients with Post-Surgical Pain
10. QRxPharma Successfully Completes Comparative Phase 1 Proof-of-Concept Study for MoxDuo(R) CR Tablet Formulation
11. QRxPharma Receives Positive Feedback from Scientific Advice Meetings in Europe on MoxDuo®IR Development and Registration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Sept. 19, 2014 "Copay coupons," ... sales of brand drugs among patients with prescription drug ... to a new report  from the Department ... Inspector General (OIG). Federal anti-kickback laws prohibit suppliers ... are subsidized by the federal government. ...
(Date:9/19/2014)... DUBLIN , September 19, 2014 /PRNewswire/ ... http://www.researchandmarkets.com/research/s6g5wm/global ) has announced the addition of ... report to their offering. ... devices have been broadly classified into wide ... are used for the treatment of different ...
(Date:9/19/2014)... 19, 2014  4WEB Medical announces the formal launch ... ankle osteotomy implants on the market today at ... meeting in Chicago .  The Osteotomy ... osteotomy needs with 74 size options included in one ... of only 15 to 18 implant sizes, which limited ...
Breaking Medicine Technology:PCMA: New OIG Report Cites Drug Manufacturer "Copay Coupon" Use in Medicare Part D 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 34WEB Medical Unveils 3D-Printed Osteotomy Truss System 2
(Date:9/21/2014)... new study of cancer patients who smoke, those using ... dependent and equally or less likely to have quit ... Cancer , a peer-reviewed journal of the American ... benefits of e-cigarettes for helping cancer patients give up ... all cancer patients who smoke should be advised to ...
(Date:9/21/2014)... UNIWIGS, one of the leading online stores of ... offers a line of human hair lace wigs inspired by ... shows people what the latest celebrity hairstyles are. ... are 4 different hairstyles to choose from: a style of ... wigs and a hot ombre red lace wig. People can ...
(Date:9/21/2014)... September 21, 2014 Hastings and Hastings, ... announces record demand for aggressively discounted accident victim attorney’s ... throughout the Valley each year, it is more important ... to discounted attorney’s fees as a way to enjoy ... Hastings has been a frontrunner when it comes to ...
(Date:9/21/2014)... 2014 More than a quarter of house ... start in one of two ways. The first type of ... The second type of dryer fire occurs when lint builds ... also catch fire due to malfunctioning electrical systems so if it ... a look!) Here are some ways that you can prevent ...
(Date:9/21/2014)... trigger an allergy to peanuts than raw peanuts, suggests ... say that specific chemical changes caused by the high ... the body,s immune system, ,priming, the body to set ... sees any peanuts. , The results might explain the ... in the Western world compared to populations in East ...
Breaking Medicine News(10 mins):Health News:E-cigarettes unhelpful in smoking cessation among cancer patients 2Health News:UniWigs New Arrivals Just In- Human Hair Lace Wigs Inspired By Famous Celebrities 2Health News:Hastings & Hastings Announces Record Demand For Aggressively Discounted Accident Victim Attorney’s Fees 2Health News:Hastings & Hastings Announces Record Demand For Aggressively Discounted Accident Victim Attorney’s Fees 3Health News:Restoration Local Offers Tips to Avoid Dryer Fires 2Health News:Restoration Local Offers Tips to Avoid Dryer Fires 3Health News:Dry roasting could help trigger peanut allergy 2
... Scottish ministers have announced a ?4 million cash boost to fight ... cash is expected to go towards stemming Scotland's high rates of ... sufferers. ,It has been estimated that about 20,000 people ... to be a "silent killer" among Scotland's drug users - in ...
... from the University of Newcastle, UK, a drug used ... the damage caused in cirrhosis of the liver.// ... scarring linked with cirrhosis is irreversible, the recent study ... by using Sulphasalazine.,Heavy drinking and obesity has resulted in ...
... reliable tests to detect early stages of cancerous growth in ... colon cancers successfully//, is often a procedure associated with a ... by going through this procedure to rule out or confirm ... fear of the discomfort they may have to go through. ...
... the young, so all anti-binge drinking sermons are by default ... fence//, it has come to light that the fifty and ... of drinks, to the extent of causing irreparable damage to ... can cause damage to the liver and brain. ...
... A new study says that uterine cancer is more lethal ... found that black women// with uterine cancer survived for 10.2 ... the same treatment. ,Dr. G. Larry Maxwell and his ... said black women were 26 percent more likely to die ...
... those who feel low during these nine months should seek ... Tommy's Baby Charity here surveyed 1,000 women about how they ... ,The survey found that three in five women ... Two thirds felt even more exhausted than they expected and ...
Cached Medicine News:Health News:Scotland’s Fight against Hepatitis C Boosted by ? 2
The Doro Halo retractor system is designed for all neurosurgical applications where retraction of the brain tissue and an armrest is required....
Molt 9, excellent for subperiosteal tunneling....
Love-Adson periosteal elevator, semi sharp, blade width 3/16" (5 mm), length 6 1/2" (165 mm)....
Iowa University periosteal elevator, blade width 11/16" (17 mm), length 7 1/4" (184 mm)....
Medicine Products: